Product Name :
Deferasirox
Description:
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It was approved by the United States Food and Drug Administration (FDA) in November 2005. Deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood.
CAS:
201530-41-8
Molecular Weight:
373.36
Formula:
C21H15N3O4
Chemical Name:
4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
Smiles :
OC1=CC=CC=C1C1=NC(=NN1C1C=CC(=CC=1)C(O)=O)C1=CC=CC=C1O
InChiKey:
BOFQWVMAQOTZIW-UHFFFAOYSA-N
InChi :
InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It was approved by the United States Food and Drug Administration (FDA) in November 2005.{{Dipotassium glycyrrhizinate} site|{Dipotassium glycyrrhizinate} Anti-infection|{Dipotassium glycyrrhizinate} Technical Information|{Dipotassium glycyrrhizinate} In Vivo|{Dipotassium glycyrrhizinate} manufacturer|{Dipotassium glycyrrhizinate} Autophagy} Deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood.{{G150} web|{G150} Cyclic GMP-AMP Synthase|{G150} Purity & Documentation|{G150} Description|{G150} supplier|{G150} Epigenetics} |Product information|CAS Number: 201530-41-8|Molecular Weight: 373.PMID:24624203 36|Formula: C21H15N3O4|Chemical Name: 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid|Smiles: OC1=CC=CC=C1C1=NC(=NN1C1C=CC(=CC=1)C(O)=O)C1=CC=CC=C1O|InChiKey: BOFQWVMAQOTZIW-UHFFFAOYSA-N|InChi: InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|